Activities of Macrophages Within and Peripheral to the Tumor Mass

  • Robert Evans
  • Stephen Haskill


The reaction of the host to the presence of a growing neoplasm is extremely complex, and it seems unlikely that any single discipline will discover why a tumor grows and progresses or why some tumors invoke different reactions than others. Both cellular and humoral reactions can be detected in many instances but how these influence the behavior of the progressing neoplasm, either individually or collectively, is still far from clear. This review, by virtue of the subject matter, is narrow in terms of understanding the immunobiology of cancer, but it is hoped that by understanding how defined systems are involved one may be able to piece together the various known facts to form a more understandable picture.


Peripheral Blood Monocyte Irradiate Mouse Macrophage Content Phagocytic Macrophage Mouse Fibrosarcoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Becker, S., and Haskill, S., 1980, Non-T-cell-mediated cytotoxicity in MSV tumor-bearing mice. III. Macrophage-mediated cytotoxicity against autochthonous MSV tumor-isolated target cells, Int. J. Cancer 25:535.PubMedCrossRefGoogle Scholar
  2. Berendt, M. J., North, R. J., and Kirstein, D. P., 1978a, The immunological basis of endotoxin-induced tumor regression: Requirement for T cell-mediated immunity, J. Exp. Med. 148:1550.PubMedCrossRefGoogle Scholar
  3. Berendt, M. J., North, R. J., and Kirstein, D. P., 1978b, The immunological basis of endotoxin-induced tumor regression: Requirement for pre-existing state of concomitant anti-tumor immunity, J. Exp. Med. 1480:1560.CrossRefGoogle Scholar
  4. Birbeck, M. S. C, and Carter, R. L., 1972, Observations on the ultrastructure of two hamster lymphomas with particular reference to infiltrating macrophages, Int. J. Cancer 9:249.PubMedCrossRefGoogle Scholar
  5. Brozna, J. P., and Ward, R. A., 1975, Anti leukotactic properties of tumor cells, J. Clin. Invest. 56:616.PubMedCrossRefGoogle Scholar
  6. Cianciolo, G. J., Matthews, T. J., Bolognesi, D. P., and Synderman, R., 1980, Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses, J. Immunol. 124:2900.PubMedGoogle Scholar
  7. Cline, M. J., and Golde, D. W., 1979, Cellular interactions in haematopoiesis, Nature (London) 277:177.CrossRefGoogle Scholar
  8. Dannenberg, A. M., And., M., Shima, K., and Tsuda, T., 1975, Macrophage turnover and activation in tuberculous granulomata, in: Mononuclear Phagocytes in Immunity, Infection and Pathology (R. Van Furth, ed.), p. 959, Blackwell Scientific Publications, Oxford.Google Scholar
  9. De Lustro, F., and Haskill, J. S., 1978, In situ cytotoxic cells in a methylcholanthrene-induced tumor, J. Immunol. 121:1007.Google Scholar
  10. Dvorak, H. F., Dvorak, A. M., Mansean, E. J., Wiberg, L., and Churchill, W. H., 1979, Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs: Role of cellular immunity, myofibroblasts, micro vascular damage and infarction in line 1 tumor regression, J. Natl. Cancer Inst. 62:1459.PubMedGoogle Scholar
  11. Eccles, S. A., and Alexander, P., 1974a, Sequestration of macrophages in growing tumours and its effect on the immunological capacity of the host, Br. J. Cancer 30:42.PubMedCrossRefGoogle Scholar
  12. Eccles, S. A., and Alexander, P., 1974b, Macrophage content of tumor in relation to metastatic spread and host immune reaction, Nature (London) 250:667.CrossRefGoogle Scholar
  13. Eccles, S. A., and Alexander, P., 1975, Immunologically-mediated restraint of latent tumor metastases, Nature (London) 257:52.CrossRefGoogle Scholar
  14. Eccles, S. A., Bandlow, G., and Alexander, P., 1976, Monocytosis associated with the growth of transplanted syngeneic rat fibrosarcomata differing in immunogenicity, Br. J. Cancer 34:20.PubMedCrossRefGoogle Scholar
  15. Evans, R., 1972, Macrophages in syngeneic animal tumors, Transplantation 14:468.PubMedCrossRefGoogle Scholar
  16. Evans, R., 1973a, Macrophages and the tumour-bearing host, Br. J. Cancer 28:19.Google Scholar
  17. Evans, R., 1973b, Specific and non-specific activation of macrophages, in: Activation of Macrophages (W. H. Wagner and H. Hahn, eds.), Second Workshop Conferences, Hoechst, Excerpta Medica, Amsterdam.Google Scholar
  18. Evans, R., 1976, Tumour macrophages in host immunity to malignancies, in: The Macrophage in Neoplasia (M. A. Fink, ed.), Academic Press, New York.Google Scholar
  19. Evans, R., 1977a, Effect of X-irradiation on host cell infiltration and growth of a murine fibrosarcoma, Br. J. Cancer 35:557.PubMedCrossRefGoogle Scholar
  20. Evans, R., 1978, Macrophage requirement for growth of a murine fibrosarcoma, Br. J. Cancer 37:1086.PubMedCrossRefGoogle Scholar
  21. Evans, R., 1979, Host cells in transplanted murine tumor and their possible relevance to tumor growth, J. Reticuloendothelial Soc. 26:427.Google Scholar
  22. Evans, R., 1980a, Further observations on the effect of cyclophosphamide on intratumor and peripheral leucocyte levels, Am. J. Pathol. 99:667.PubMedGoogle Scholar
  23. Evans, R., 1980b, Macrophage accumulation in primary and transplanted tumors growing in C5-deficient BlO.Dy mice, Int. J. Cancer 26:227.PubMedCrossRefGoogle Scholar
  24. Evans, R., and Alexander, P., 1976, Mechanisms of extra-cellular killing of nucleated mammalian cells by macrophages, in: Immunobiology of the Macrophage, (D. S. Nelson, ed.), pp. 536–576, Academic Press, New York.Google Scholar
  25. Evans, R., and Lawler, E. M., 1980, Macrophage content and immunogenicity of C57B/6J and BALB/cByJ methylcholanthrene-induced sarcomas, Int. J. Cancer 26:831.PubMedCrossRefGoogle Scholar
  26. Evans, R., Madison, L. D., and Eidlen, D. M., 1980, Cyclophosphamide-induced changes in the cellular composition of a methylcholanthrene-induced tumor and their relation to bone marrow and blood leukocyte levels, Cancer Res. 40:395.PubMedGoogle Scholar
  27. Facchinetti, T., Raz, A., and Goldman, R., 1978, A differential interaction of daunomycin, adriamycin, and n-trifluoracetyladriamycin-14-valerate with mouse peritoneal macrophages, Cancer Res. 38:3944.PubMedGoogle Scholar
  28. Fauve, R. M., Hevin, B., Jacob, H., Gaillard, J. A., and Jacob, F., 1974, Anti-inflammatory effects of murine malignant cells, Proc. Natl. Acad. Sci. USA 71:4052.PubMedCrossRefGoogle Scholar
  29. Fidler, I. J., Raz, A., Fogler, W. E., Kirsh, R., Bugelski, P., and Poste, G., Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophage, Cancer Res. 40:4460.Google Scholar
  30. Fromer, C. H., and Klintworth, G. K., 1976, An evaluation of the role of leukocytes in the patho-genesis of experimentally induced corneal vascularization, Am. J. Pathol. 82:157.PubMedGoogle Scholar
  31. Haskill, J. S., 1981, Unit gravity sedimentation of tumor-associated macrophage, in: Manual Macrophage Methodology (Herscowitz, H. B., Holden, H. T., Bellanti, J. A., and Gaffar, A., eds.), p. 81, Marcel Dekker, Inc., New York.Google Scholar
  32. Haskill, J. S., and Parthenais, E., 1978, Immunological factors influencing the intra-tumor localization of ADCC effector cells, J. Immunol. 120:1813.PubMedGoogle Scholar
  33. Haskill, J. S., Proctor, J. W., and Yamamura, Y., 1975a, Host responses within solid tumors. I. Monocytic effector cells within rat sarcomas, J. Natl. Cancer Inst. 54:387.PubMedGoogle Scholar
  34. Haskill, J. S., Yamamura, Y., and Radov, L., 1975b, Host responses within solid tumors: Non-thymus-derived specific cytotoxic cells within a murine mammary adenocarcinoma, Int. J. Cancer 16:798.PubMedCrossRefGoogle Scholar
  35. Haskill, J. S., Hayry, P., and Radov, L. A., 1978, Systemic and local immunity in allograft and cancer rejection, in: Contemporary Topics in Immunobiology, Vol. 8 (N. L. Warner and M. D. Cooper, eds.), pp. 107–170, Plenum Press, New York.CrossRefGoogle Scholar
  36. Haskill, J. S., Propst, R. H., and Hayes, M., 1980, Cell cycle specific effects of activated macrophages, Fifth International Symposium on Flow Cytometry, Rome, December 1980, Abstract.Google Scholar
  37. Herberman, R. B., Holden, H. T., Varesio, L., Taniyama, T., Puccetti, P., Kirchner, H., Gerson, J., White, S., Keisar, Y., and Haskill, J. S., 1979, Immunologic reactivity of lymphoid cells in tumors, in: Contemporary Topics in Immunobiology, Vol. 10 (I. P. Witz and M. G. Hanna, eds.), Plenum Press, New York.Google Scholar
  38. Hibberd, A. D., and Metcalf, D., 1971, Proliferation of macrophage and granulocyte precursors in response to primary and transplanted tumors, J. Med. Sci. 7:202.Google Scholar
  39. Hibbs, J. B., Jr., 1975, Activated macrophages as cytotoxic effector cells. I. Inhibition of specific and non-specific tumor resistance by trypan blue, Transplantation 19:77.PubMedCrossRefGoogle Scholar
  40. Hoffman, M. K., Oettgen, H. F., Old, L. J., Mittler, R. S., and Hammerling, U., 1978, Induction and immunological properties of tumor necrosis factor, J. Reticuloendothelial Soc. 23:307.Google Scholar
  41. Holden, H. T., Haskill, J. S., Kirchner, H., and Herberman, R. B., 1976, Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors, J. Immunol. 117:440.PubMedGoogle Scholar
  42. Ioachim, H. L., 1976, The stromal reaction of tumors: An expression of immune surveillance, J. Natl. Cancer Inst. 57:465.PubMedGoogle Scholar
  43. Kaminski, M., Kaminska, G., Jacobisiak, M., and Brzezinski, W., 1977, Inhibition of lymphocyte-induced engiogenesis of isolated chondrocytes, Nature 268:238.PubMedCrossRefGoogle Scholar
  44. Keller, R., 1976, Promotion of tumor growth in vivo by anti-macrophage agents, J. Natl. Cancer Inst. 57:1355.PubMedGoogle Scholar
  45. Kerbel, R. S., Pross, H. F., and Elliot, E. V., 1975, Origin and partial characterization of Fc receptor-bearing cells found within experimental carcinomas and sarcomas, Int. J. Cancer 15:918.PubMedCrossRefGoogle Scholar
  46. Key, M., and Haskill, J. S., 1981, Macrophage-mediated, antibody-dependent destruction of tumor cells in DBAJ2 mice: In vitro identification of an in situ mechanism, J. Natl. Cancer Inst. 66:103.PubMedGoogle Scholar
  47. Lappat, E. J., and Cawein, M., 1964, A study of the leukemoid response to transplantable A-280 tumor in mice, Cancer Res. 24:302.PubMedGoogle Scholar
  48. Lauder, I., Aherne, W., Stewart, J., and Sainsbury, R., 1977, Macrophage infiltration of breast tumours: A prospective study, J. Clin. Pathol. 30:563.PubMedCrossRefGoogle Scholar
  49. MacCarty, W. C., and Mahle, A. E., 1921, Relation of differentiation and lymphocytic infiltration to postoperative longevity in gastric carcinoma, J. Lab. Clin. Med. 6:473.Google Scholar
  50. Mantovani, A., 1978, Effects on in vitro tumor growth of murine macrophages isolated from sarcoma lines differing in immunogenicity and metastasizing capacity, Int. J. Cancer 22:741.PubMedCrossRefGoogle Scholar
  51. Meltzer, M. S., Stevenson, M. M., and Leonard, E. J., 1977, Characterization of macrophage chemo- taxins in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors, Cancer Res. 37:721.PubMedGoogle Scholar
  52. Moore, K., and Moore, M., 1977, Intratumour host cells of transplanted rat neoplasms of different immunogenicities, Int. J. Cancer 19:803.PubMedCrossRefGoogle Scholar
  53. Normann, S. J., and Cornelius, J., 1978, Concomitant depression of tumor macrophage infiltration and systemic inflammation by progressive cancer growth, Cancer Res. 38:3453.PubMedGoogle Scholar
  54. Normann, S. J., Schardt, M., and Sorkin, E., 1977, Do tumors escape surveillance by depression of macrophage inflammation?, in: The Macrophage and Cancer (K. James, W. McBride, and A. Stuart, eds.), Econoprint, Edinburgh.Google Scholar
  55. Parthenais, E., and Haskill, J. S., 1979, Immunity to the T1699 murine mammary tumor. II. Thymic influence on the in situ inflammatory response, metastatic growth and invasiveness, J. Immunol. 123:1334.PubMedGoogle Scholar
  56. Pike, M. C., and Snyderman, R., 1976, Depression of macrophage function by a factor produced by neoplasms: A mechanism for abrogation of immune surveillance, J. Immunol. 117:1243.PubMedGoogle Scholar
  57. Polverini, P. J., Cotran, R. S., Gimbrone, M. A., and Unanue, E. R., 1977, Activated macrophages induce vascular proliferation, Nature (London) 209:804.CrossRefGoogle Scholar
  58. Prehn, R. T., 1976, Do tumors grow because of the immune response of the host?, Transplant. Rev. 28:34.PubMedGoogle Scholar
  59. Rhodes, J., Bishop, M., and Benfield, J., 1979, Tumor surveillance: How tumors may resist mac-rophage-mediated host defense, Science 203:179.PubMedCrossRefGoogle Scholar
  60. Ruco, L. P., and Meltzer, M. S., 1978, Macrophage activation for tumor cytotoxicity: Tumoricidal activity by macrophages from C3H/HeJ mice requires at least two activation stimuli, Cell. Immunol. 41:35.PubMedCrossRefGoogle Scholar
  61. Russell, S. W., Doe, W. F., and Cochrane, C. G., 1976, Number of macrophages and distribution of mitotic activity in regressing and progressing Moloney sarcomas, J. Immunol. 116:164.Google Scholar
  62. Russell, S. W., Doe, W. F., and Mclntosh, A. T., 1977, A non-cytolytic stage of macrophage activation in Moloney sarcomas, in: The Macrophage and Cancer (K. James, B. McBride, and A. Stuart, eds.), Econoprint, Edinburgh.Google Scholar
  63. Salmon, S. E., and Hamburger, A. W., 1978, Immunoproliferation and cancer: A common mac-rophage-derived promoter substance, Lancet 1:1289.PubMedCrossRefGoogle Scholar
  64. Smith, J. B., Mclntosh, G. H., and Morris, B., 1970, The migration of cells through chronically inflamed tissues, J. Pathol. 100:21.PubMedCrossRefGoogle Scholar
  65. Snyderman, R., and Pike, M. C., 1976, An inhibitor of macrophage chemotaxis produced by neoplasms, Science 192:370.PubMedCrossRefGoogle Scholar
  66. Stephens, T. C., Currie, G. A., and Peacock, J. H., 1978, Repopulation of X-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors, Br. J. Cancer 38:573.PubMedCrossRefGoogle Scholar
  67. Stoychkov, N. J., Schultz, R. M., Chirigos, M. A., Pavlidas, N. A., and Goldin, A., 1979, Effects of adriamycin and cyclophosphamide treatment on induction of macrophage cytotoxic function in mice, Cancer Res. 39:3014.PubMedGoogle Scholar
  68. Stutman, O., 1975, Delayed tumor appearance and absence of regression in nude mice infected with murine sarcoma virus, Nature (London) 253:142.CrossRefGoogle Scholar
  69. Tracey, D. E., and Silberman, S. L., 1980, Host-derived antibody-dependent cytotoxic cells within murine tumors, J. Natl. Cancer Inst. 64:111.PubMedGoogle Scholar
  70. Van Loveren, H., and Den Otter, W., 1974, In vitro activation of armed macrophages and the therapeutic application in mice, J. Natl. Cancer Inst. 52:1917.PubMedGoogle Scholar
  71. Witz, I. P., 1977, Tumor-bound immunoglobulins in situ expression of tumor immunity, Adv. Cancer Res. 25:95.PubMedCrossRefGoogle Scholar
  72. Wood, G. N., and Gillespie, G. Y., 1975, Studies on the role of macrophages in regulation of growth and metastasis of murine chemically induced fibrosarcomas, Int. J. Cancer 16:1022.PubMedCrossRefGoogle Scholar
  73. Wood, G. W., Morantz, R. A., Tilzer, S. A., and Gollahon, K. A., 1980, Immunoglobulin bound in vivo to Fc receptor-positive cells in human CNS tumors, J. Natl. Cancer Inst. 64:411.PubMedGoogle Scholar
  74. Underwood, J. C, and Carr, I., 1972, The lymphoreticular infiltrate in human tumours studied by electron microscopy and tissue culture, J. Pathol. 107:v.Google Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Robert Evans
    • 1
  • Stephen Haskill
    • 2
  1. 1.The Jackson LaboratoryBar HarborUSA
  2. 2.Department of Obstetrics and Gynecology, School of MedicineUniversity of North CarolinaChapel HillUSA

Personalised recommendations